NYSE$MED
Medifast Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Medifast's second quarter results were announced, revealing a decrease in revenue due to a decline in active earning OPTAVIA Coaches and their productivity, while strategic initiatives aimed at efficiency and cost reduction helped mitigate the impact of economic headwinds.
Medifast reported a decrease in revenue for Q2 2023, driven by a decline in active OPTAVIA Coaches and their productivity. However, strategic initiatives focused on efficiency and cost reduction helped mitigate the impact of economic headwinds. The company is also advancing its health and wellness agenda with the launch of new products and pilot programs.
- Revenue decreased by 34.7% to $296.2 million compared to Q2 2022, driven by a decrease in active earning OPTAVIA Coaches and their productivity.
- The average revenue per active earning OPTAVIA Coach was $5,578, a 16.3% decline compared to $6,667 in Q2 2022.
- Net income was $30.3 million, or $2.77 per diluted share, compared to $39.1 million, or $3.42 per diluted share, in Q2 2022.
- Cash and cash equivalents totaled $147.4 million with no interest-bearing debt.
Headline financials
Revenue & EPS history
Medifast · Revenue · Quarterly
$296M
Forward guidance
The Company expects third quarter 2023 revenue to be in the range of $220 million to $240 million and third quarter 2023 diluted EPS to be in the range of $0.71 to $1.32
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
+0.2%
Avg return
Earnings day
+0.5%
Avg return
5 days after
+0.4%
Avg return
30 days after
51%
33 / 65 earnings
Positive
+31.6%
Q4 2017
Best reaction
-29.9%
Q3 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +19.7% | +16.7% | |
| Q4 2025 | -0.8% | -1.9% | -7.4% | |
| Q3 2025 | +0.8% | +0.4% | -8.6% | |
| Q1 2025 | -0.6% | +5.3% | +10.8% | |
| Q4 2024 | -11.4% | -8.4% | -11.1% | |
| Q3 2024 | +9.8% | +3.1% | +6.2% | |
| Q2 2024 | -5.6% | -9.0% | -11.8% | |
| Q1 2024 | -18.3% | -20.8% | -25.4% | |
| Q4 2023 | -19.2% | -18.5% | -28.7% | |
| Q3 2023 | -1.5% | -6.5% | +3.3% | |
| Q2 2023 | -9.5% | -4.9% | -18.5% | |
| Q1 2023 | -3.8% | -0.7% | -14.1% | |
| Q4 2022 | -10.8% | -4.6% | -15.3% | |
| Q3 2022 | -3.2% | -1.6% | +9.0% | |
| Q2 2022 | -15.2% | -21.9% | -31.9% | |
| Q1 2022 | +5.4% | +1.8% | -2.0% | |
| Q4 2021 | -5.6% | +1.7% | -6.4% | |
| Q3 2021 | +3.7% | +4.7% | -7.1% | |
| Q2 2021 | -8.7% | -14.1% | -17.4% | |
| Q1 2021 | +7.8% | +18.9% | +35.3% | |
| Q4 2020 | -3.9% | -0.8% | -14.7% | |
| Q3 2020 | +12.9% | +23.5% | +45.4% | |
| Q2 2020 | -5.7% | -5.0% | -8.0% | |
| Q1 2020 | +18.5% | +30.1% | +46.7% | |
| Q4 2019 | -9.7% | -13.4% | -31.5% | |
| Q3 2019 | -29.9% | -24.8% | -14.7% | |
| Q2 2019 | -7.6% | -7.8% | -10.5% | |
| Q1 2019 | -2.1% | +3.6% | -12.1% | |
| Q4 2018 | +0.9% | -0.7% | +0.3% | |
| Q3 2018 | -28.3% | -25.3% | -32.4% | |
| Q2 2018 | +25.8% | +17.4% | +35.0% | |
| Q1 2018 | +22.3% | +19.3% | +50.0% | |
| Q4 2017 | +31.6% | +32.5% | +44.0% | |
| Q3 2017 | +14.7% | +13.1% | +16.6% | |
| Q2 2017 | +18.6% | +20.7% | +31.7% | |
| Q1 2017 | +3.4% | +3.8% | -6.1% | |
| Q4 2016 | -3.7% | -4.4% | -1.4% | |
| Q3 2016 | -5.0% | -4.5% | -4.7% | |
| Q2 2016 | -0.2% | +0.8% | +5.9% | |
| Q1 2016 | +0.8% | — | — | |
| Q4 2015 | -5.6% | — | — | |
| Q3 2015 | +6.9% | — | — | |
| Q2 2015 | -9.2% | — | — | |
| Q1 2015 | +5.3% | — | — | |
| Q4 2014 | -3.1% | — | — | |
| Q3 2014 | +2.5% | — | — | |
| Q2 2014 | -9.5% | — | — | |
| Q1 2014 | -8.5% | — | — | |
| Q4 2013 | +3.4% | — | — | |
| Q3 2013 | +0.5% | — | — | |
| Q2 2013 | -4.3% | — | — | |
| Q1 2013 | -3.8% | — | — | |
| Q4 2012 | -5.4% | — | — | |
| Q3 2012 | +10.4% | — | — | |
| Q2 2012 | +28.5% | — | — | |
| Q1 2011 | +8.9% | — | — | |
| Q1 2012 | +3.2% | — | — | |
| Q4 2011 | +0.9% | — | — | |
| Q4 2009 | +0.9% | — | — | |
| Q3 2010 | +1.9% | — | — | |
| Q3 2011 | +1.9% | — | — | |
| Q4 2010 | +4.3% | — | — | |
| Q2 2010 | +4.3% | — | — | |
| Q2 2011 | +4.3% | — | — | |
| Q1 2010 | +10.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro